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Abstract	  
Purpose:	  Sonodynamic	  therapy	  (SDT)	  is	  a	  therapeutic	  approach	  in	  which	  ultrasound	  irradiation	  is	  used	  to	  promote	  
the	  generation	  of	  cytotoxic	  species	  via	  the	  excitation	  of	  particular	  chemical	  compounds	  (sonosensitizers).	  The	  aim	  
of	   this	   study	   is	   to	   investigate	  cancer	   targeted	  gold	  nanoparticles	   (AuNPs)	   in	   their	   role	  as	  nanosonosensitizers	   to	  
increase	  the	  acoustic	  cavitation	  effect,	  typically	  associated	  with	  sonodynamic	  therapy.	  
Experimental	  description:	  AuNPs	  have	  been	  produced	  via	  the	  reduction	  of	  tetrachlorauric	  acid	  with	  sodium	  citrate	  
and	  decorated	  with	  2	  kDa	  mPEG-­‐SH	  and	  3.5	  kDa	  folate-­‐PEG-­‐SH	  (FA-­‐PEG-­‐AuNPs),	  which	  acts	  as	  a	  targeting	  agent	  for	  
the	  biorecognition	  of	  folate	  receptor	  expressing	  cancer	  cells.	  In	  vitro	  experiments	  were	  performed	  on	  human	  cell	  
lines	  that	  express	  a	  folate	  receptor,	   i.e.	  epidermoid	  carcinoma	  KB	  and	  colon	  carcinoma	  HCT116,	  and	  that	  do	  not	  
express	  a	  folate	  receptor,	  i.e.	  breast	  cancer	  MCF-­‐7.	  Cell	  association	  has	  been	  investigated	  using	  atomic	  absorption	  
spectrometry.	  FA-­‐PEG-­‐AuNP's	  ability	  to	  selectively	  kill	  cancer	  cells	  under	  US	  field	  exposure	  has	  been	  studied	  at	  1.8	  
MHz	  and	  two	  different	  energy	  densities	  inside	  the	  cell	  tube;	  8x10-­‐6	  J	  cm-­‐2	  for	  5	  minutes	  (USn)	  and	  8x10
-­‐5	  J	  cm-­‐2	  for	  5	  
minutes	  (USt).	  The	  treatment's	  effect	  on	  cell	  growth	  has	  been	  investigated	  using	  a	  WST-­‐1	  proliferation	  assay,	  cell	  
death	   and	   reactive	   oxygen	   species	   (ROS)	   production	   studied	   using	   flow	   cytometric	   analysis	   (FCA).	   Experiments	  
have	   also	   been	   carried	   out	  with	   the	   free	   radical	   scavenger	   N-­‐acetylcysteine	   (NAC)	   to	   assess	   the	   role	   of	   ROS	   in	  
cancer	  cell	  death.	  
Results:	   FA-­‐PEG-­‐AuNPs	   selectively	   target	   folate	   receptor	   expressing	   cancer	   cells,	   KB	   and	   HCT116,	   and	   do	   not	  
associate	  with	  MCF-­‐7	  cells	  that	  do	  not	  express	  folate	  receptors.	  A	  significant	  reduction	  in	  cancer	  cell	  growth	  was	  
only	   observed	   in	   folate	   receptor	   expressing	   cells,	   KB	   and	   HCT116,	   upon	   incubation	  with	   FA-­‐PEG-­‐AuNPs	   and	  US	  
treatment,	  as	  compared	  to	  control	  conditions,	  72	  hours	  from	  sonodynamic	  treatment.	  Moreover,	  FCA	  only	  showed	  
a	  significant	  increase	  in	  necrotic	  cells	  in	  KB	  and	  HCT116	  cells	  that	  had	  been	  treated	  with	  FA-­‐PEG-­‐AuNPs	  and	  US	  at	  
the	  two	  different	  energy	  densities.	  A	  specific	  ROS	  production	  pattern	  was	  also	  observed	  after	  FA-­‐PEG-­‐AuNPs	  and	  
US	   treatment	   at	   the	   two	   different	   energy	   densities.	   Interestingly,	   NAC	   only	   suppresses	   cyototoxicity	   and	   ROS	  
production	  when	  used	  with	   the	   lower	  energy	  density	  US	   treatment	   (USn),	  while	   it	   seems	  to	  play	  a	  minor	   role	   in	  
suppressing	  these	  effects	  at	  the	  higher	  energy	  density	  (USt),	  which	  displayed	  a	  moderate	  hyperthermic	  condition.	  
Conclusions:	  The	  simultaneous	  exploitation	  of	  the	  targeting	  capacity	  of	  the	  gold	  nanoparticles	  and	  the	  sensitizing	  
effect	  afforded	  by	  ultrasound,	  make	  FA-­‐PEG-­‐AuNPs	  promising	  nanosonosensitizers	  for	  the	  site-­‐specific	  ultrasound-­‐
based	  treatment	  of	  cancer.	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